VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
EVAX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
EVAXEvaxion Biotech A/S
$3.38$21M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksEVAXQuarterly Cash Flow

Evaxion Biotech A/S (EVAX) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Evaxion Biotech A/S (EVAX) quarterly cash flow statement — complete operating, investing & financing history

EVAX Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21
Cash from Operations00000000-2.01M-4.39M00-5.83M-6.57M-5.19M-8.19M-4.12M-6.29M-7.49M-4.04M
Operating CF Margin %---------2749.32%-----------
Operating CF Growth %----100%100%--65.58%33.15%100%100%-41.7%-4.32%30.69%-102.87%6.33%-127.67%--36.78%
Net Income-5.91M4.62M-4.83M-1.58M-3.6M-1.94M-6.2M1.19M-4.52M-5.68M-5.68M-6.27M-6.87M-5.74M-4.77M-5.79M-8.37M-5.25M-6.82M-4.09M
Depreciation & Amortization00000000115K200K00571K0000000
Stock-Based Compensation00000000-21K100K00-58K300K0000400K0
Deferred Taxes00000000000000000000
Other Non-Cash Items5.91M-4.62M4.83M1.58M3.6M1.94M6.2M-1.19M1.52M281K5.68M6.27M63K-326K-849K-226K2.41M-139K-331K-980K
Working Capital Changes00000000904K707K00465K-801K427K-2.17M1.84M-906K-738K1.04M
Change in Receivables00000000707K800K00-1.49M1.1M-1.1K00000
Change in Inventory00000000000000000000
Change in Payables00000000000000000000
Cash from Investing000000001K-65K0056K-88K-77K-159K-177K-331K-495K-327K
Capital Expenditures000000001K-65K0061K-89K-83K-181K-176K-332K-510K-282K
CapEx % of Revenue--------1.37%-----------
Acquisitions00000000000000000000
Investments--------------------
Other Investing000000000000-5K1K6K22K-1K1K15K-45K
Cash from Financing000000005.26M96K00546K-131K-300K7.74M24.65M-65K-35K25.25M
Debt Issued (Net)00000000-118K000-189K0-107K7.74M-144K-67K-35K-43K
Equity Issued (Net)0000000000000028K025.95M1K027.9M
Dividends Paid00000000000000000000
Share Repurchases00000000000000000000
Other Financing000000005.38M96K00735K-131K-221K0-1.16M1K0-2.6M
Net Change in Cash12.66M0001.38M006.15M2.98M-4.51M-3.12M-2.94M-4.67M-7.4M-6.16M-757K20.22M-6.86M-8.16M21.12M
Free Cash Flow00000000-2.01M-4.46M00-5.77M-6.66M-5.27M-8.37M-4.29M-6.63M-8M-4.38M
FCF Margin %---------2747.95%-----------
FCF Growth %----100%100%--65.23%33.07%100%100%-34.47%-0.44%34.07%-91.16%8.19%-139.5%--45.22%
FCF per Share---------2.94-6.44---9.56-11.17-8.85-14.45-7.92-13.81-16.89-9.84
FCF Conversion (FCF/Net Income)--------0.44x0.77x--0.85x1.14x1.09x1.41x0.49x1.20x1.10x0.99x
Interest Paid00000000000016K000001K0
Taxes Paid00000000000000000000